Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
CRISPR Therapeutics AG (CRSP)
USD50.63
-2.72 (-5.10%)
CH NASDAQ Healthcare Biotechnology
Address
Baarerstrasse 14 6300
Zug, CH
Zug, CH
CEO
Samarth Kulkarni
Website
crisprtx.com
IPO
2016-10-19
CIK 1674416 ISIN CH0334081137
Description
CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its exclusive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, which enables precise and targeted alterations to an organism's genetic code. Its extensive pipeline includes therapeutic candidates spanning multiple medical areas, such as blood disorders (hemoglobinopathies), various cancers (oncology), regenerative medicine, and rare conditions. The company's flagship investigational therapy is CTX001, an ex vivo CRISPR gene-edited treatment. This therapy aims to benefit patients with transfusion-dependent beta-thalassemia or severe sickle cell disease by modifying their own hematopoietic stem cells to markedly boost the production of fetal hemoglobin within red blood cells. CRISPR Therapeutics is also advancing several other genetically engineered allogeneic (donor-sourced) CAR-T investigational therapies: CTX110, designed to combat cluster of differentiation 19-positive malignancies; CTX120, which targets B-cell maturation antigen for multiple myeloma that has relapsed or proven resistant to previous treatments; and CTX130, focused on Cluster of Differentiation 70 for a spectrum of solid tumors and blood cancers. Furthermore, the company is developing VCTX210, an immune-evasive, gene-edited stem cell-derived product candidate for treating type 1 diabetes. It is also pursuing various in vivo gene-editing initiatives aimed at addressing disorders affecting the liver, lungs, muscles, and central nervous system. The company has forged strategic alliances with significant partners, including Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, ViaCyte, Inc., Nkarta, Inc., and Capsida Biotherapeutics. CRISPR Therapeutics AG was established in 2013 and maintains its headquarters in Zug, Switzerland.
News Sentiment (7d)
8 articles
- CRISPR Therapeutics AG (CRSP) Stock Dips While Market Gains: Key Facts Zacks Investment Research
- Over 2 Billion Reasons to Love CRISPR Therapeutics Right Now The Motley Fool
- Progress Report: How Our Top Stock Picks of 2026 Are Faring Schaeffers Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD50.63
-2.72 (-5.10%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.70
Float Shares
96.04M
Free Float %
99.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.35% | +10.85% | +7.34% | -6.58% | +5.07% | +7.13% | +54.81% | -13.07% | -51.49% | +298.72% | +298.72% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (38 ratings, all time)
Buy
Price Targets & DCF
Current price
50.63
Low
33.00
-34.8%
Consensus
64.60
+27.6%
Median
76.00
+50.1%
High
82.00
+62.0%
Ratings Trend (MoM)
62% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | -1 |
| Buy | 12 | -1 |
| Hold | 9 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
66.00
+30.4%
|
| Last Quarter | 2 |
66.00
+30.4%
|
| Last Year | 9 |
66.22
+30.8%
|
| All Time | 29 |
94.70
+87.0%
|
Quality scores
Altman Z-Score
2.72
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-90.0% Q1'26: +68.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-49.1% Q1'26: +19.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-13,718.1% Q1'26: -7,503.5% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-16,191.4% Q1'26: -8,933.3% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-166.7% Q1'26: -324.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+6.6% Q1'26: +11.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.72× Q1'26: -1.56× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 16 Rev. Ana. 18 EPS Ana. |
Dec 2027 15 Rev. Ana. 16 EPS Ana. |
Dec 2028 11 Rev. Ana. 9 EPS Ana. |
Dec 2029 5 Rev. Ana. 3 EPS Ana. |
Dec 2030 5 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.16M
est: 5.00M (+3.3%)
|
41.00M
est: 11.64M (+252.3%)
|
3.12M
est: 6.05M (-48.3%)
|
289.59M
est: 257.81M (+12.3%)
|
719.0K
est: 2.32M (-69.0%)
|
913.08M
est: 903.86M (+1.0%)
|
436.0K
est: 6.14M (-92.9%)
|
370.00M
est: 202.23M (+83.0%)
|
35.00M
est: 11.17M (+213.4%)
|
3.51M
est: 7.05M (-50.2%)
|
39.56M
3.20M – 144.22M
+461.2% YoY
|
137.61M
2.10M – 534.95M
+247.8% YoY
|
580.29M
554.79M – 605.78M
+321.7% YoY
|
2.21B
46.37M – 7.97B
+280.9% YoY
|
5.50B
115.45M – 19.85B
+149.0% YoY
|
| EBITDA |
-13.67M
est: -3.12M (-338.2%)
|
-61.62M
est: -7.26M (-748.9%)
|
-155.42M
est: -123.93M (-25.4%)
|
51.47M
est: -160.83M (+132.0%)
|
-345.25M
est: -274.45M (-25.8%)
|
391.48M
est: 357.26M (+9.6%)
|
-648.99M
est: -573.30M (-13.2%)
|
-202.70M
est: -126.15M (-60.7%)
|
-447.31M
est: -6.97M (-6,321.6%)
|
-548.84M
est: -4.40M (-12,379.3%)
|
-24.68M
-89.97M – -2.00M
-461.2% YoY
|
-85.84M
-333.71M – -1.31M
-247.8% YoY
|
-361.99M
-377.90M – -346.09M
-321.7% YoY
|
-1.38B
-4.97B – -28.92M
-280.9% YoY
|
-3.43B
-12.38B – -72.02M
-149.0% YoY
|
| EBIT |
-14.67M
est: -3.19M (-359.5%)
|
-64.65M
est: -7.43M (-770.1%)
|
-158.94M
est: -122.29M (-30.0%)
|
46.74M
est: -164.60M (+128.4%)
|
-354.44M
est: -287.22M (-23.4%)
|
373.53M
est: 334.13M (+11.8%)
|
-673.16M
est: -604.11M (-11.4%)
|
-222.54M
est: -129.12M (-72.4%)
|
-466.57M
est: -7.13M (-6,444.3%)
|
-568.32M
est: -4.50M (-12,525.6%)
|
-25.26M
-92.08M – -2.05M
-461.2% YoY
|
-87.86M
-341.55M – -1.34M
-247.8% YoY
|
-370.50M
-386.78M – -354.22M
-321.7% YoY
|
-1.41B
-5.09B – -29.60M
-280.9% YoY
|
-3.51B
-12.67B – -73.71M
-149.0% YoY
|
| Net Income |
-23.20M
est: -187.28M (+87.6%)
|
-68.36M
est: -200.63M (+65.9%)
|
-164.98M
est: -127.17M (-29.7%)
|
66.86M
est: 548.33M (-87.8%)
|
-348.87M
est: -282.52M (-23.5%)
|
377.66M
est: 338.20M (+11.7%)
|
-650.18M
est: -415.93M (-56.3%)
|
-153.61M
est: -265.80M (+42.2%)
|
-366.25M
est: -467.80M (+21.7%)
|
-581.60M
est: -568.53M (-2.3%)
|
-479.09M
-519.60M – -352.58M
+15.7% YoY
|
-371.77M
-475.10M – -131.14M
+22.4% YoY
|
-169.89M
-779.20M – 822.03M
+54.3% YoY
|
261.48M
-71.31M – 1.15B
+253.9% YoY
|
1.39B
-378.04M – 6.08B
+430.1% YoY
|
| SGA |
31.06M
est: 356.67M (-91.3%)
|
35.85M
est: 830.07M (-95.7%)
|
48.29M
est: 431.24M (-88.8%)
|
63.49M
est: 134.81M (-52.9%)
|
85.75M
est: 165.38M (-48.2%)
|
99.69M
est: 99.11M (+0.6%)
|
102.46M
est: 438.23M (-76.6%)
|
76.16M
est: 10.45B (-99.3%)
|
72.98M
est: 576.98M (-87.4%)
|
73.54M
est: 364.30M (-79.8%)
|
2.04B
165.54M – 7.45B
+461.2% YoY
|
7.11B
108.61M – 27.64B
+247.8% YoY
|
29.98B
28.67B – 31.30B
+321.7% YoY
|
114.20B
2.40B – 411.92B
+280.9% YoY
|
284.35B
5.97B – 1.03T
+149.0% YoY
|
| EPS |
-1.89
est: -2.22 (+14.9%)
|
-1.71
est: -2.38 (+28.1%)
|
-3.44
est: -3.28 (-4.8%)
|
1.23
est: 0.01 (+15,890.6%)
|
-5.29
est: -5.02 (-5.3%)
|
4.97
est: 4.88 (+1.8%)
|
-8.36
est: -9.09 (+8.0%)
|
-1.94
est: -3.26 (+40.5%)
|
-4.34
est: -5.16 (+15.9%)
|
-6.47
est: -6.21 (-4.1%)
|
-4.87
-5.78 – -3.92
+21.5% YoY
|
-3.62
-5.28 – -1.46
+25.8% YoY
|
-2.26
-8.66 – 9.14
+37.5% YoY
|
2.91
-0.79 – 12.76
+228.6% YoY
|
15.41
-4.20 – 67.65
+430.1% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-13 | Bernstein | Market Perform | Market Perform | Maintain |
| 2026-05-06 | Citigroup | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-434.39M
OE per share TTM
-4.77
Owner's Yield
-8.05%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
101.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
521
Total invested
3.67B
Insider transactions (90d)
0
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management LLC | 9.09M | 11.88% | 8.16M | 702.4K | 9.09M | — | IA | — | 2022-02-09 | ↗ |
| 2 | Nikko Asset Management Americas, Inc. | 4.32M | 5.64% | — | 3.87M | — | 4.32M | IA | USA | 2022-02-14 | ↗ |
| 3 | Nikko Asset Management Co., Ltd. (“NAM”) | 4.32M | 5.64% | — | 4.32M | — | 4.32M | FI, IA, HC | Japan | 2022-02-04 | ↗ |
| 4 | Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”) | 4.32M | 5.64% | — | 4.32M | — | 4.32M | FI, HC | Japan | 2022-02-04 | ↗ |
| 5 | CELGENE ALPINE INVESTMENT CO. III, LLC | 2.80M | 6.10% | — | 2.80M | — | 10.00 | OO | Delaware, U.S.A. | 2018-02-08 | ↗ |
| 6 | CELGENE CORPORATION | 2.80M | 6.10% | — | 2.80M | — | 10.00 | CO | Delaware, U.S.A. | 2018-02-08 | ↗ |
| 7 | Vertex Pharmaceuticals (Europe) Limited (“Vertex Europe”) | 2.69M | 4.40% | — | 2.69M | — | 2.69M | OO | — | 2020-02-13 | ↗ |
| 8 | Vertex Pharmaceuticals Incorporated (“Vertex US”) | 2.69M | 4.40% | — | 2.69M | — | 2.69M | CO | — | 2020-02-13 | ↗ |
| 9 | Abingworth Bioventures VI, LP 98-1059389 | 2.16M | 5.30% | — | — | — | — | PN | England | 2017-08-14 | ↗ |
| 10 | Abingworth LLP 98-051-8585 | 2.16M | 5.30% | — | — | — | — | PN | England | 2017-08-14 | ↗ |
| 11 | Versant Ventures IV, LLC | 1.34M | 1.90% | — | 1.34M | — | 1.34M | OO | — | 2021-02-16 | ↗ |
| 12 | Versant Venture Capital IV, L.P. | 1.34M | 1.90% | 1.34M | — | 1.34M | — | PN | — | 2021-02-16 | ↗ |
| 13 | Versant Ventures V, LLC | 1.27M | 1.80% | — | 1.27M | — | 1.27M | OO | — | 2021-02-16 | ↗ |
| 14 | Versant Venture Capital V, L.P. | 1.19M | 1.70% | 1.19M | — | 1.19M | — | PN | — | 2021-02-16 | ↗ |
| 15 | Versant Venture Management, LLC | 339.8K | 0.50% | 339.8K | — | 339.8K | — | OO | — | 2021-02-16 | ↗ |
| 16 | GP-GP | 90.7K | 0.10% | — | 90.7K | — | 90.7K | CO | — | 2021-02-16 | ↗ |
| 17 | Versant Venture Capital V (Canada) LP | 90.7K | 0.10% | 90.7K | — | 90.7K | — | PN | — | 2021-02-16 | ↗ |
| 18 | Versant Venture Capital V (Canada), L.P. | 90.7K | 0.10% | 90.7K | — | 90.7K | — | PN | — | 2020-09-18 | ↗ |
| 19 | Versant Ventures V (Canada), L.P. | 90.7K | 0.10% | — | 90.7K | — | 90.7K | PN | — | 2021-02-16 | ↗ |
| 20 | Versant Ophthalmic Affiliates Fund I, L.P. | 38.8K | 0.10% | 38.8K | — | 38.8K | — | PN | — | 2021-02-16 | ↗ |
| 21 | Versant Affiliates Fund V, L.P. | 35.0K | 0.00% | 35.0K | — | 35.0K | — | PN | — | 2021-02-16 | ↗ |
| 22 | Versant Side Fund IV, L.P. | 7.9K | 0.00% | 7.9K | — | 7.9K | — | PN | — | 2021-02-16 | ↗ |
| 23 | 95-1411037 | 13.00 | 7.10% | 5.52M | — | 5.56M | — | IA | Delaware | 2023-02-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
521
+2 vs prev Q
New positions
78
Closed positions
79
Increased
258
Reduced
116
Put/Call ratio
0.84
Calls held
2.09M
Puts held
1.75M
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARK INVESTMENT MANAGEMENT LLC | 10.52M +735.1K (+7.5%) | 551.78M -82.5M (-13.0%) | 11.52% +0.284 pp | 3.66% -0.114 pp | USD63.43 -17.3% | 35 qtrs — |
| 2 | BLACKROCK, INC. | 7.51M +458.0K (+6.5%) | 393.73M -63.2M (-13.8%) | 8.35% +0.252 pp | 0.01% -0.001 pp | USD50.41 +4.0% | 6 qtrs — |
| 3 | ORBIS ALLAN GRAY LTD | 5.95M +968.1K (+19.4%) | 312.03M -10.9M (-3.4%) | 6.62% +0.895 pp | 1.31% -0.078 pp | USD52.77 -0.6% | 5 qtrs — |
| 4 | CAPITAL INTERNATIONAL INVESTORS | 5.89M +243.5K (+4.3%) | 309.02M -57.1M (-15.6%) | 6.45% -0.034 pp | 0.05% -0.011 pp | USD67.03 -21.8% | 30 qtrs — |
| 5 | STATE STREET CORP | 3.75M -253.8K (-6.3%) | 196.83M -62.9M (-24.2%) | 4.17% -0.428 pp | 0.01% -0.002 pp | USD54.51 -3.8% | 31 qtrs — |
| 6 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.23M -56.0K (-1.7%) | 169.20M -43.5M (-20.5%) | 3.59% -0.182 pp | 0.11% -0.023 pp | USD51.69 +1.5% | 14 qtrs — |
| 7 | GSK PLC | 3.22M +3.2M (+100.0%) | 168.89M +168.9M (+100.0%) | 3.53% +3.527 pp | 21.14% +21.137 pp | USD52.44 +0.0% | 1 qtrs NEW |
| 8 | UBS GROUP AG | 2.52M +185.1K (+7.9%) | 132.37M -19.2M (-12.7%) | 2.81% +0.121 pp | 0.02% -0.002 pp | USD46.04 +13.9% | 37 qtrs — |
| 9 | VANGUARD GROUP INC | 2.27M -96.3K (-4.1%) | 118.95M -34.3M (-22.4%) | 2.52% -0.193 pp | 0.00% -0.001 pp | USD60.63 -13.5% | 35 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.25M +108.1K (+5.0%) | 117.97M -20.8M (-15.0%) | 2.50% +0.042 pp | 0.01% -0.002 pp | USD54.14 -3.1% | 37 qtrs — |
| 11 | SR ONE CAPITAL MANAGEMENT, LP | 2.04M +— (+0.0%) | 106.91M -25.2M (-19.1%) | 2.23% -0.109 pp | 15.14% -3.975 pp | USD66.54 -21.2% | 8 qtrs — |
| 12 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.96M -205.6K (-9.5%) | 102.68M -37.5M (-26.8%) | 2.14% -0.340 pp | 0.06% -0.020 pp | USD62.77 -16.5% | 16 qtrs — |
| 13 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 1.96M -205.6K (-9.5%) | 102.61M -37.6M (-26.8%) | 2.14% -0.340 pp | 1.19% -0.173 pp | USD55.54 -5.6% | 30 qtrs — |
| 14 | FMR LLC | 1.95M +68.3K (+3.6%) | 102.47M -19.7M (-16.2%) | 2.17% +0.007 pp | 0.01% -0.001 pp | USD61.99 -15.4% | 31 qtrs — |
| 15 | ECOR1 CAPITAL, LLC | 1.39M +— (+0.0%) | 72.85M -17.2M (-19.1%) | 1.54% -0.051 pp | 3.31% -1.015 pp | USD68.18 -23.1% | 8 qtrs — |
| 16 | BANK OF AMERICA CORP /DE/ | 1.10M -27.2K (-2.4%) | 57.52M -15.3M (-21.0%) | 1.22% -0.071 pp | 0.00% -0.001 pp | USD58.92 -11.0% | 37 qtrs — |
| 17 | NEA MANAGEMENT COMPANY, LLC | 1.06M +— (+0.0%) | 55.51M -13.1M (-19.1%) | 1.18% -0.039 pp | 2.83% -0.934 pp | USD22.19 +136.3% | 37 qtrs — |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.03M +44.4K (+4.5%) | 54.02M -9.9M (-15.4%) | 1.13% -0.004 pp | 0.01% -0.002 pp | USD59.22 -11.4% | 16 qtrs — |
| 19 | DIMENSIONAL FUND ADVISORS LP | 907.1K +30.1K (+3.4%) | 47.57M -9.3M (-16.3%) | 0.99% -0.014 pp | 0.01% -0.002 pp | USD58.59 -10.5% | 25 qtrs — |
| 20 | LOOMIS SAYLES & CO L P | 899.3K -10.4K (-1.1%) | 47.16M -11.8M (-20.0%) | 0.99% -0.060 pp | 0.06% -0.013 pp | USD126.26 -58.5% | 19 qtrs — |
| 21 | NORTHERN TRUST CORP | 755.1K -24.8K (-3.2%) | 39.60M -10.9M (-21.7%) | 0.84% -0.056 pp | 0.01% -0.001 pp | USD52.32 +0.2% | 32 qtrs — |
| 22 | MORGAN STANLEY | 667.1K -730.8K (-52.3%) | 34.98M -55.6M (-61.4%) | 0.74% -0.864 pp | 0.00% -0.003 pp | USD58.76 -10.8% | 37 qtrs — |
| 23 | SQUAREPOINT OPS LLC | 581.1K +581.1K (+100.0%) | 30.47M +30.5M (+100.0%) | 0.64% +0.636 pp | 0.03% +0.032 pp | USD52.44 +0.0% | 14 qtrs — |
| 24 | JANE STREET GROUP, LLC | 561.4K +203.1K (+56.7%) | 29.44M +6.2M (+26.8%) | 0.62% +0.213 pp | 0.00% +0.001 pp | USD50.62 +3.6% | 6 qtrs — |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 550.4K -600.0 (-0.1%) | 28.86M -6.8M (-19.2%) | 0.61% -0.021 pp | 0.00% -0.001 pp | USD48.32 +8.5% | 33 qtrs — |
| 26 | JPMORGAN CHASE & CO | 543.0K -50.5K (-8.5%) | 28.47M -10.0M (-26.0%) | 0.59% -0.087 pp | 0.00% -0.001 pp | USD74.10 -29.2% | 34 qtrs — |
| 27 | NORGES BANK | 490.2K +490.2K (+100.0%) | 25.71M +25.7M (+100.0%) | 0.54% +0.537 pp | 0.00% +0.003 pp | USD52.44 +0.0% | 1 qtrs NEW |
| 28 | TWO SIGMA INVESTMENTS, LP | 470.6K -574.1K (-55.0%) | 24.68M -43.0M (-63.5%) | 0.52% -0.677 pp | 0.03% -0.066 pp | USD39.41 +33.1% | 33 qtrs — |
| 29 | CAPTION MANAGEMENT, LLC | 457.1K +3.5K (+0.8%) | 23.97M -5.4M (-18.5%) | 0.51% -0.013 pp | 0.16% -0.065 pp | USD53.06 -1.2% | 20 qtrs — |
| 30 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 389.5K +106.4K (+37.6%) | 20.43M +2.1M (+11.3%) | 0.43% +0.102 pp | 1.41% +0.166 pp | USD51.78 +1.3% | 7 qtrs — |
| 31 | D. E. SHAW & CO., INC. | 381.1K +20.8K (+5.8%) | 19.98M -3.4M (-14.4%) | 0.42% +0.010 pp | 0.01% -0.002 pp | USD60.85 -13.8% | 25 qtrs — |
| 32 | WELLS FARGO & COMPANY/MN | 318.9K +15.7K (+5.2%) | 16.72M -2.9M (-14.9%) | 0.35% +0.006 pp | 0.00% -0.001 pp | USD57.23 -8.4% | 37 qtrs — |
| 33 | BANK OF NEW YORK MELLON CORP | 311.0K +6.3K (+2.1%) | 16.31M -3.4M (-17.4%) | 0.34% -0.009 pp | 0.00% -0.001 pp | USD54.82 -4.3% | 34 qtrs — |
| 34 | AMERIPRISE FINANCIAL INC | 297.2K -14.6K (-4.7%) | 15.57M -4.7M (-23.2%) | 0.33% -0.028 pp | 0.00% -0.001 pp | USD55.44 -5.4% | 32 qtrs — |
| 35 | GOLDMAN SACHS GROUP INC | 275.6K +42.1K (+18.0%) | 14.45M -681.7K (-4.5%) | 0.31% +0.038 pp | 0.00% 0.000 pp | USD56.33 -6.9% | 33 qtrs — |
| 36 | PEAK6 LLC | 274.5K -96.6K (-26.0%) | 14.39M -9.7M (-40.1%) | 0.31% -0.121 pp | 0.03% -0.009 pp | USD34.18 +53.4% | 5 qtrs — |
| 37 | CITADEL ADVISORS LLC | 267.7K +100.6K (+60.2%) | 14.04M +3.2M (+29.6%) | 0.30% +0.106 pp | 0.00% +0.001 pp | USD58.84 -10.9% | 25 qtrs — |
| 38 | BARCLAYS PLC | 250.0K +120.1K (+92.5%) | 13.11M +7.0M (+114.9%) | 0.28% +0.129 pp | 0.00% +0.002 pp | USD50.38 +4.1% | 34 qtrs — |
| 39 | VESTMARK ADVISORY SOLUTIONS, INC. | 249.5K +10.6K (+4.4%) | 13.09M -2.4M (-15.5%) | 0.27% -0.001 pp | 0.18% -0.119 pp | USD52.59 -0.3% | 9 qtrs — |
| 40 | NUVEEN, LLC | 183.4K +543.0 (+0.3%) | 9.62M -2.2M (-18.8%) | 0.20% -0.006 pp | 0.00% -0.001 pp | USD48.65 +7.8% | 3 qtrs — |
| 41 | PICTET ASSET MANAGEMENT HOLDING SA | 167.5K -25.1K (-13.0%) | 9.02M -3.3M (-26.6%) | 0.18% -0.038 pp | 0.01% -0.003 pp | USD60.73 -13.7% | 10 qtrs — |
| 42 | LPL FINANCIAL LLC | 170.8K -40.2K (-19.1%) | 8.96M -4.7M (-34.5%) | 0.19% -0.055 pp | 0.00% -0.002 pp | USD60.89 -13.9% | 32 qtrs — |
| 43 | RAYMOND JAMES FINANCIAL INC | 167.1K +57.3K (+52.2%) | 8.77M +1.6M (+23.1%) | 0.19% +0.060 pp | 0.00% +0.000 pp | USD46.17 +13.6% | 5 qtrs — |
| 44 | ROYAL BANK OF CANADA | 165.6K -300.6K (-64.5%) | 8.68M -21.5M (-71.3%) | 0.18% -0.351 pp | 0.00% -0.004 pp | USD55.88 -6.2% | 36 qtrs — |
| 45 | TWO SIGMA ADVISERS, LP | 162.4K -410.6K (-71.7%) | 8.52M -28.6M (-77.1%) | 0.18% -0.478 pp | 0.02% -0.058 pp | USD40.63 +29.1% | 6 qtrs — |
| 46 | SWISS NATIONAL BANK | 161.5K +2.4K (+1.5%) | 8.47M -1.8M (-17.9%) | 0.18% -0.006 pp | 0.01% -0.001 pp | USD68.51 -23.5% | 31 qtrs — |
| 47 | TD ASSET MANAGEMENT INC | 158.4K -16.2K (-9.3%) | 8.31M -3.0M (-26.6%) | 0.17% -0.027 pp | 0.01% -0.003 pp | USD54.84 -4.4% | 21 qtrs — |
| 48 | CONTRARIUS GROUP HOLDINGS LTD | 156.6K -113.7K (-42.1%) | 8.21M -9.3M (-53.1%) | 0.17% -0.139 pp | 0.40% -0.395 pp | USD40.42 +29.7% | 5 qtrs — |
| 49 | UBS ASSET MANAGEMENT AMERICAS INC | 148.9K +148.9K (+100.0%) | 7.81M +7.8M (+100.0%) | 0.16% +0.163 pp | 0.00% +0.002 pp | USD52.44 +0.0% | 24 qtrs — |
| 50 | VERSANT VENTURE MANAGEMENT, LLC | 148.8K +— (+0.0%) | 7.80M -1.8M (-19.1%) | 0.16% -0.008 pp | 5.17% +0.626 pp | USD44.16 +18.8% | 32 qtrs — |
| 51 | CITIGROUP INC | 132.7K +72.2K (+119.4%) | 6.96M +3.0M (+77.5%) | 0.15% +0.076 pp | 0.00% +0.001 pp | USD46.37 +13.1% | 33 qtrs — |
| 52 | MAREX GROUP PLC | 127.5K +3.8K (+3.1%) | 6.69M -1.3M (-16.6%) | 0.14% -0.003 pp | 0.04% -0.015 pp | USD61.97 -15.4% | 3 qtrs — |
| 53 | NO STREET GP LP | 125.0K +125.0K (+100.0%) | 6.56M +6.6M (+100.0%) | 0.14% +0.139 pp | 0.44% +0.441 pp | USD52.44 +0.0% | 1 qtrs NEW |
| 54 | RHUMBLINE ADVISERS | 118.8K -5.1K (-4.1%) | 6.23M -1.8M (-22.4%) | 0.13% -0.010 pp | 0.01% -0.001 pp | USD48.64 +7.8% | 3 qtrs — |
| 55 | REYNDERS MCVEIGH CAPITAL MANAGEMENT, LLC | 116.5K +3.5K (+3.1%) | 6.11M -1.2M (-16.6%) | 0.13% -0.002 pp | 0.29% -0.057 pp | USD51.88 +1.1% | 22 qtrs — |
| 56 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 116.1K +6.7K (+6.2%) | 6.09M -999.9K (-14.1%) | 0.13% +0.002 pp | 0.00% -0.001 pp | USD68.30 -23.2% | 31 qtrs — |
| 57 | DIADEMA PARTNERS LP | 112.7K +700.0 (+0.6%) | 5.91M -1.3M (-18.6%) | 0.13% -0.003 pp | 1.02% -0.839 pp | USD39.44 +33.0% | 5 qtrs — |
| 58 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 112.7K -35.9K (-24.1%) | 5.91M -3.7M (-38.6%) | 0.13% -0.045 pp | 0.01% -0.008 pp | USD63.39 -17.3% | 31 qtrs — |
| 59 | PRIVATE ADVISOR GROUP, LLC | 107.3K -10.9K (-9.2%) | 5.62M -2.0M (-26.5%) | 0.12% -0.016 pp | 0.03% -0.011 pp | USD49.13 +6.7% | 27 qtrs — |
| 60 | ALGERT GLOBAL LLC | 102.9K +102.9K (+100.0%) | 5.39M +5.4M (+100.0%) | 0.11% +0.114 pp | 0.08% +0.084 pp | USD52.44 +0.0% | 1 qtrs NEW |
| 61 | RAFFERTY ASSET MANAGEMENT, LLC | 101.0K -53.3K (-34.5%) | 5.30M -4.7M (-47.0%) | 0.11% -0.065 pp | 0.02% -0.014 pp | USD60.52 -13.4% | 19 qtrs — |
| 62 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 89.4K +5.3K (+6.4%) | 5.20M -733.6K (-12.4%) | 0.10% +0.001 pp | 0.01% -0.002 pp | USD40.51 +29.4% | 10 qtrs — |
| 63 | BECK BODE, LLC | 98.8K +98.8K (+100.0%) | 5.18M +5.2M (+100.0%) | 0.11% +0.108 pp | 0.86% +0.862 pp | USD52.44 +0.0% | 1 qtrs NEW |
| 64 | ALLIANCEBERNSTEIN L.P. | 96.4K +10.0K (+11.6%) | 5.05M -542.3K (-9.7%) | 0.11% +0.008 pp | 0.00% 0.000 pp | USD49.04 +6.9% | 3 qtrs — |
| 65 | CAPITAL INTERNATIONAL SARL | 94.8K -4.9K (-4.9%) | 4.97M -1.5M (-23.1%) | 0.10% -0.011 pp | 0.08% -0.032 pp | USD58.42 -10.2% | 22 qtrs — |
| 66 | BAKER CHAD R | 93.3K +65.0 (+0.1%) | 4.96M -1.1M (-17.9%) | 0.10% -0.005 pp | 0.89% -0.150 pp | USD53.45 -1.9% | 10 qtrs — |
| 67 | GROUP ONE TRADING, L.P. | 94.0K -3.3K (-3.4%) | 4.93M -1.4M (-21.8%) | 0.10% -0.007 pp | 0.01% -0.003 pp | USD63.87 -17.9% | 21 qtrs — |
| 68 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 89.7K -9.5K (-9.6%) | 4.71M -1.7M (-26.7%) | 0.10% -0.014 pp | 0.01% -0.003 pp | USD50.59 +3.7% | 7 qtrs — |
| 69 | LEGAL & GENERAL GROUP PLC | 87.9K -4.6K (-4.9%) | 4.61M -1.4M (-23.1%) | 0.10% -0.010 pp | 0.00% 0.000 pp | USD64.26 -18.4% | 31 qtrs — |
| 70 | VAN ECK ASSOCIATES CORP | 85.8K +2.2K (+2.6%) | 4.50M -920.0K (-17.0%) | 0.10% -0.001 pp | 0.00% -0.001 pp | USD40.84 +28.4% | 20 qtrs — |
| 71 | PRICE T ROWE ASSOCIATES INC /MD/ | 84.9K +8.4K (+11.0%) | 4.46M -506.0K (-10.2%) | 0.09% +0.007 pp | 0.00% 0.000 pp | USD54.39 -3.6% | 31 qtrs — |
| 72 | HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 84.4K +12.1K (+16.7%) | 4.43M -262.9K (-5.6%) | 0.09% +0.011 pp | 0.27% -0.014 pp | USD56.61 -7.4% | 9 qtrs — |
| 73 | NEO IVY CAPITAL MANAGEMENT | 78.7K +78.7K (+100.0%) | 4.13M +4.1M (+100.0%) | 0.09% +0.088 pp | 0.65% +0.652 pp | USD52.44 +0.0% | 1 qtrs NEW |
| 74 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 78.1K +3.2K (+4.3%) | 4.10M -758.2K (-15.6%) | 0.09% +0.001 pp | 0.00% -0.001 pp | USD90.20 -41.9% | 18 qtrs — |
| 75 | COMMONWEALTH EQUITY SERVICES, LLC | 78.1K +9.0K (+13.0%) | 4.10M -381.8K (-8.5%) | 0.09% +0.008 pp | 0.01% 0.000 pp | USD60.86 -13.8% | 8 qtrs — |
| 76 | SLOW CAPITAL, INC. | 76.6K +3.3K (+4.6%) | 4.02M -731.3K (-15.4%) | 0.08% 0.000 pp | 0.48% -0.078 pp | USD54.21 -3.3% | 28 qtrs — |
| 77 | BALYASNY ASSET MANAGEMENT L.P. | 71.2K +22.1K (+45.0%) | 3.73M +551.6K (+17.3%) | 0.08% +0.023 pp | 0.00% +0.001 pp | USD60.97 -14.0% | 2 qtrs — |
| 78 | WALLEYE TRADING LLC | 70.6K -27.0K (-27.7%) | 3.70M -2.6M (-41.5%) | 0.08% -0.034 pp | 0.01% -0.004 pp | USD48.57 +8.0% | 30 qtrs — |
| 79 | DEUTSCHE BANK AG\ | 70.5K +5.7K (+8.8%) | 3.70M -503.2K (-12.0%) | 0.08% +0.003 pp | 0.00% 0.000 pp | USD50.10 +4.7% | 36 qtrs — |
| 80 | NWAM LLC | 61.8K -39.9K (-39.2%) | 3.38M -4.1M (-55.1%) | 0.07% -0.049 pp | 0.19% -0.220 pp | USD61.90 -15.3% | 3 qtrs — |
| 81 | CETERA INVESTMENT ADVISERS | 63.9K +83.0 (+0.1%) | 3.35M -785.3K (-19.0%) | 0.07% -0.002 pp | 0.00% -0.001 pp | USD55.19 -5.0% | 21 qtrs — |
| 82 | CONGRESS ASSET MANAGEMENT CO /MA | 63.3K -4.8K (-7.0%) | 3.32M -1.1M (-24.8%) | 0.07% -0.008 pp | 0.02% -0.006 pp | USD53.15 -1.3% | 10 qtrs — |
| 83 | INVESCO LTD. | 60.8K -4.5K (-6.9%) | 3.19M -1.0M (-24.7%) | 0.07% -0.007 pp | 0.00% 0.000 pp | USD64.84 -19.1% | 26 qtrs — |
| 84 | JEFFERIES FINANCIAL GROUP INC. | 60.0K +— (+0.0%) | 3.15M -742.2K (-19.1%) | 0.07% -0.003 pp | 0.02% -0.002 pp | USD64.81 -19.1% | 2 qtrs — |
| 85 | ADVISOR GROUP HOLDINGS, INC. | 59.2K +3.3K (+5.9%) | 3.10M -101.1K (-3.2%) | 0.07% +0.002 pp | 0.00% +0.000 pp | USD62.91 -16.6% | 24 qtrs — |
| 86 | JONES FINANCIAL COMPANIES LLLP | 57.5K +12.8K (+28.6%) | 3.01M +257.1K (+9.3%) | 0.06% +0.013 pp | 0.00% +0.000 pp | USD51.00 +2.8% | 8 qtrs — |
| 87 | EVERSOURCE WEALTH ADVISORS, LLC | 57.5K -40.0K (-41.0%) | 3.01M -3.3M (-52.3%) | 0.06% -0.048 pp | 0.11% -0.139 pp | USD36.70 +42.9% | 17 qtrs — |
| 88 | GUGGENHEIM CAPITAL LLC | 57.0K -440.0 (-0.8%) | 2.99M -733.9K (-19.7%) | 0.06% -0.003 pp | 0.02% -0.006 pp | USD71.46 -26.6% | 21 qtrs — |
| 89 | ENVESTNET ASSET MANAGEMENT INC | 56.6K -13.8K (-19.6%) | 2.97M -1.6M (-35.0%) | 0.06% -0.018 pp | 0.00% 0.000 pp | USD62.77 -16.5% | 22 qtrs — |
| 90 | GREEN ALPHA ADVISORS, LLC | 55.7K +725.0 (+1.3%) | 2.92M -642.5K (-18.0%) | 0.06% -0.002 pp | 2.68% -0.764 pp | USD44.36 +18.2% | 21 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.66
Neutral
Ratio by volume
1.42
Neutral
Buys
23
Sells
35
Shares acquired
585.3K
Shares disposed
412.0K
Cash buys
—
Cash sales
19.00
Net activity
+173,294
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | Prasad Raju | Officer | S-Sale | D | Common Shares | 3,708 | 46.78 | 173.5K | 15,565 | D | ↗ |
| 2026-03-23 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 10,020 | 46.78 | 468.7K | 255,501 | D | ↗ |
| 2026-03-23 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 3,182 | 46.78 | 148.9K | 94,308 | D | ↗ |
| 2026-03-20 | Prasad Raju | Officer | M-Exempt | D | Restricted Stock Units | 6,250 | 0.00 | — | 12,500 | D | ↗ |
| 2026-03-20 | Patel Naimish | Officer | A-Award | A | Restricted Stock Units | 30,000 | 0.00 | — | 30,000 | D | ↗ |
| 2026-03-20 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 19,687 | 0.00 | — | 39,375 | D | ↗ |
| 2026-03-20 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 6,250 | 0.00 | — | 97,490 | D | ↗ |
| 2026-03-16 | Prasad Raju | Officer | S-Sale | D | Common Shares | 5,848 | 48.26 | 282.2K | 17,794 | D | ↗ |
| 2026-03-16 | Patel Naimish | Officer | S-Sale | D | Common Shares | 3,150 | 48.26 | 152.0K | 13,143 | D | ↗ |
| 2026-03-16 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 10,349 | 48.26 | 499.4K | 245,834 | D | ↗ |
| 2026-03-16 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 3,450 | 48.26 | 166.5K | 91,240 | D | ↗ |
| 2026-03-14 | Prasad Raju | Officer | M-Exempt | D | Restricted Stock Units | 6,875 | 0.00 | — | 20,625 | D | ↗ |
| 2026-03-14 | Patel Naimish | Officer | M-Exempt | A | Common Shares | 8,125 | 0.00 | — | 16,293 | D | ↗ |
| 2026-03-14 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 20,625 | 0.00 | — | 61,875 | D | ↗ |
| 2026-03-14 | KASINGER JAMES R. | Officer | M-Exempt | D | Restricted Stock Units | 6,875 | 0.00 | — | 20,625 | D | ↗ |
| 2026-03-11 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 9,798 | 52.80 | 517.3K | 235,558 | D | ↗ |
| 2026-03-11 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 2,800 | 52.80 | 147.8K | 87,815 | D | ↗ |
| 2026-03-10 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 19,250 | 0.00 | — | 245,356 | D | ↗ |
| 2026-03-10 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 5,500 | 0.00 | — | 90,615 | D | ↗ |
| 2026-02-19 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 6,967 | 52.58 | 366.3K | 226,106 | D | ↗ |
| 2026-02-19 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 2,112 | 52.58 | 111.0K | 85,115 | D | ↗ |
| 2026-02-18 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 13,250 | 0.00 | — | 233,073 | D | ↗ |
| 2026-02-18 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 3,825 | 0.00 | — | 87,227 | D | ↗ |
| 2026-01-22 | Prasad Raju | Officer | M-Exempt | D | Stock Option (Right to Buy) | 34,972 | 45.15 | 1.58M | 41,667 | D | ↗ |
| 2026-01-22 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 60,000 | 60.23 | 3.61M | 134,201 | D | ↗ |
| 2026-01-20 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 21,433 | 51.61 | 1.11M | 202,768 | D | ↗ |
| 2026-01-06 | Prasad Raju | Officer | M-Exempt | D | Stock Option (Right to Buy) | 23,361 | 45.15 | 1.05M | 76,639 | D | ↗ |
| 2025-12-22 | Prasad Raju | Officer | S-Sale | D | Common Shares | 3,528 | 55.10 | 194.4K | 13,239 | D | ↗ |
| 2025-12-18 | Kulkarni Samarth | Director / Officer | G-Gift | D | Common Shares | 30,000 | 0.00 | — | 224,201 | D | ↗ |
| 2025-10-17 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 50,895 | 67.91 | 3.46M | 254,201 | D | ↗ |
| 2025-10-16 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 100,000 | 0.00 | — | 305,096 | D | ↗ |
| 2025-10-14 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 4,242 | 66.60 | 282.5K | 205,096 | D | ↗ |
| 2025-10-14 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 1,076 | 66.60 | 71.7K | 83,402 | D | ↗ |
| 2025-10-13 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 8,334 | 0.00 | — | 209,338 | D | ↗ |
| 2025-10-13 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 2,114 | 0.00 | — | 84,478 | D | ↗ |
| 2025-10-03 | Prasad Raju | Officer | A-Award | A | Stock Option (Right to Buy) | 16,500 | 67.74 | 1.12M | 16,500 | D | ↗ |
| 2025-10-03 | Patel Naimish | Officer | A-Award | A | Stock Option (Right to Buy) | 16,500 | 67.74 | 1.12M | 16,500 | D | ↗ |
| 2025-10-03 | Kulkarni Samarth | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 49,500 | 67.74 | 3.35M | 49,500 | D | ↗ |
| 2025-10-03 | KASINGER JAMES R. | Officer | A-Award | A | Stock Option (Right to Buy) | 16,500 | 67.74 | 1.12M | 16,500 | D | ↗ |
| 2025-09-17 | Kulkarni Samarth | Director / Officer | G-Gift | D | Common Shares | 6,000 | 0.00 | — | 201,004 | D | ↗ |
| 2025-08-18 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 13,081 | 58.15 | 760.7K | 207,004 | D | ↗ |
| 2025-08-16 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 25,000 | 0.00 | — | 220,085 | D | ↗ |
| 2025-08-06 | Treco Douglas A | Director | P-Purchase | A | Common Shares | 20,000 | 57.03 | 1.14M | 22,000 | D | ↗ |
| 2025-07-16 | George Simeon | Director | P-Purchase | A | Common Shares | 960,983 | 52.03 | 50.00M | 1,730,179 | I | ↗ |
| 2025-06-05 | Treco Douglas A | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | Rommel Christian | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | Morrison Briggs | Director | — | — | Stock Option (Right to Buy) | 26,000 | 48.68 | 1.27M | 0 | D | ↗ |
| 2025-06-05 | Mahatme Sandesh | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | High Katherine A | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | Greene John | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | George Simeon | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | Fleming Harold Edward | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | Fardis Maria | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-06-05 | Behbahani Ali | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 38.57 | 501.4K | 13,000 | D | ↗ |
| 2025-05-30 | Prasad Raju | Officer | A-Award | A | Restricted Stock Units | 20,000 | 0.00 | — | 20,000 | D | ↗ |
| 2025-05-30 | Patel Naimish | Officer | A-Award | A | Restricted Stock Units | 25,000 | 0.00 | — | 25,000 | D | ↗ |
| 2025-05-29 | Patel Naimish | Officer | S-Sale | D | Common Shares | 3,932 | 35.94 | 141.3K | 6,068 | D | ↗ |
| 2025-05-28 | Patel Naimish | Officer | M-Exempt | A | Common Shares | 10,000 | 0.00 | — | 10,000 | D | ↗ |
| 2025-04-03 | Patel Naimish | Officer | P-Purchase | A | Common Shares | 1,508 | 32.96 | 49.7K | 1,508 | D | ↗ |
| 2025-03-21 | Prasad Raju | Officer | S-Sale | D | Common Shares | 2,197 | 41.23 | 90.6K | 16,767 | D | ↗ |
| 2025-03-21 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 10,031 | 41.23 | 413.6K | 195,085 | D | ↗ |
| 2025-03-21 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 3,185 | 41.23 | 131.3K | 81,729 | D | ↗ |
| 2025-03-21 | Bruno Julianne | Officer | S-Sale | D | Common Shares | 1,714 | 41.23 | 70.7K | 10,544 | D | ↗ |
| 2025-03-20 | Prasad Raju | Officer | M-Exempt | D | Restricted Stock Units | 6,250 | 0.00 | — | 18,750 | D | ↗ |
| 2025-03-20 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 19,688 | 0.00 | — | 59,062 | D | ↗ |
| 2025-03-20 | KASINGER JAMES R. | Officer | M-Exempt | D | Restricted Stock Units | 6,250 | 0.00 | — | 18,750 | D | ↗ |
| 2025-03-20 | Bruno Julianne | Officer | M-Exempt | A | Common Shares | 3,750 | 0.00 | — | 12,258 | D | ↗ |
| 2025-03-17 | Prasad Raju | Officer | S-Sale | D | Common Shares | 3,762 | 41.80 | 157.3K | 12,714 | D | ↗ |
| 2025-03-14 | Prasad Raju | Officer | M-Exempt | D | Restricted Stock Units | 10,000 | 0.00 | — | 20,000 | D | ↗ |
| 2025-03-14 | Patel Naimish | Officer | A-Award | A | Stock Option (Right to Buy) | 46,667 | 42.12 | 1.97M | 46,667 | D | ↗ |
| 2025-03-14 | Kulkarni Samarth | Director / Officer | A-Award | A | Restricted Stock Units | 82,500 | 0.00 | — | 82,500 | D | ↗ |
| 2025-03-14 | KASINGER JAMES R. | Officer | A-Award | A | Restricted Stock Units | 27,500 | 0.00 | — | 27,500 | D | ↗ |
| 2025-03-14 | Bruno Julianne | Officer | A-Award | A | Restricted Stock Units | 27,500 | 0.00 | — | 27,500 | D | ↗ |
| 2025-03-12 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 4,462 | 43.32 | 193.3K | 185,428 | D | ↗ |
| 2025-03-12 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 1,116 | 43.32 | 48.3K | 78,664 | D | ↗ |
| 2025-03-12 | Bruno Julianne | Officer | S-Sale | D | Common Shares | 190 | 43.32 | 8.2K | 8,508 | D | ↗ |
| 2025-03-11 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 9,973 | 42.42 | 423.1K | 180,890 | D | ↗ |
| 2025-03-11 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 2,850 | 42.42 | 120.9K | 77,530 | D | ↗ |
| 2025-03-11 | Bruno Julianne | Officer | M-Exempt | A | Common Shares | 435 | 0.00 | — | 8,698 | D | ↗ |
| 2025-03-10 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 19,250 | 0.00 | — | 38,500 | D | ↗ |
| 2025-03-10 | KASINGER JAMES R. | Officer | M-Exempt | D | Restricted Stock Units | 5,500 | 0.00 | — | 11,000 | D | ↗ |
| 2025-03-10 | Bruno Julianne | Officer | M-Exempt | D | Restricted Stock Units | 2,399 | 0.00 | — | 4,796 | D | ↗ |
| 2025-02-26 | Greene John | Director | P-Purchase | A | Common Shares | 7,000 | 44.85 | 313.9K | 7,000 | D | ↗ |
| 2025-02-19 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 18,360 | 55.21 | 1.01M | 171,613 | D | ↗ |
| 2025-02-19 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 1,947 | 52.80 | 102.8K | 74,880 | D | ↗ |
| 2025-02-19 | Bruno Julianne | Officer | S-Sale | D | Common Shares | 333 | 52.80 | 17.6K | 7,062 | D | ↗ |
| 2025-02-18 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 13,250 | 0.00 | — | 13,250 | D | ↗ |
| 2025-02-18 | KASINGER JAMES R. | Officer | M-Exempt | D | Restricted Stock Units | 3,825 | 0.00 | — | 3,825 | D | ↗ |
| 2025-02-18 | Bruno Julianne | Officer | M-Exempt | D | Restricted Stock Units | 650 | 0.00 | — | 650 | D | ↗ |
| 2025-02-16 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 20,000 | 0.00 | — | 82,597 | D | ↗ |
| 2024-12-24 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 13,751 | 16.21 | 222.9K | 195,291 | D | ↗ |
| 2024-12-02 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 15,000 | 55.10 | 826.6K | 181,540 | D | ↗ |
| 2024-11-11 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 23,121 | 55.43 | 1.28M | 203,419 | D | ↗ |
| 2024-10-16 | Prasad Raju | Officer | A-Award | A | Stock Option (Right to Buy) | 18,333 | 49.00 | 898.3K | 18,333 | D | ↗ |
| 2024-10-16 | Patel Naimish | Officer | A-Award | A | Stock Option (Right to Buy) | 18,333 | 49.00 | 898.3K | 18,333 | D | ↗ |
| 2024-10-16 | Kulkarni Samarth | Director / Officer | A-Award | A | Restricted Stock Units | 400,000 | 0.00 | — | 400,000 | D | ↗ |
| 2024-10-16 | KASINGER JAMES R. | Officer | A-Award | A | Restricted Stock Units | 30,000 | 0.00 | — | 30,000 | D | ↗ |
| 2024-10-16 | Bruno Julianne | Officer | A-Award | A | Stock Option (Right to Buy) | 18,333 | 49.00 | 898.3K | 18,333 | D | ↗ |
| 2024-10-14 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 4,293 | 46.28 | 198.7K | 226,540 | D | ↗ |
| 2024-10-14 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 1,089 | 46.28 | 50.4K | 62,597 | D | ↗ |
| 2024-10-13 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 8,333 | 0.00 | — | 16,667 | D | ↗ |
| 2024-10-13 | KASINGER JAMES R. | Officer | M-Exempt | D | Restricted Stock Units | 2,113 | 0.00 | — | 4,227 | D | ↗ |
| 2024-08-08 | Kulkarni Samarth | Director / Officer | G-Gift | D | Common Shares | 100,000 | 0.00 | — | 222,500 | — | ↗ |
| 2024-06-21 | Bruno Julianne | Officer | S-Sale | D | Common Shares | 3,366 | 56.09 | 188.8K | 6,745 | — | ↗ |
| 2024-06-20 | Bruno Julianne | Officer | M-Exempt | A | Common Shares | 7,000 | 0.00 | — | 10,111 | — | ↗ |
| 2024-05-30 | Treco Douglas A | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 54.06 | 702.8K | 13,000 | — | ↗ |
| 2024-05-30 | Rommel Christian | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-30 | Mahatme Sandesh | Director | — | D | Stock Option (Right to Buy) | 26,000 | 44.81 | 1.17M | 0 | — | ↗ |
| 2024-05-30 | High Katherine A | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 54.06 | 702.8K | 13,000 | — | ↗ |
| 2024-05-30 | Greene John | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 54.06 | 702.8K | 13,000 | — | ↗ |
| 2024-05-30 | George Simeon | Director | A-Award | A | Stock Option (Right to buy) | 13,000 | 54.06 | 702.8K | 13,000 | — | ↗ |
| 2024-05-30 | Fleming Harold Edward | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 54.06 | 702.8K | 13,000 | — | ↗ |
| 2024-05-30 | Fardis Maria | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 54.06 | 702.8K | 13,000 | — | ↗ |
| 2024-05-30 | Behbahani Ali | Director | A-Award | A | Stock Option (Right to buy) | 13,000 | 54.06 | 702.8K | 13,000 | — | ↗ |
| 2024-05-28 | Patel Naimish | Officer | A-Award | A | Stock Option (Right to Buy) | 85,000 | 54.84 | 4.66M | 85,000 | — | ↗ |
| 2024-05-23 | Bruno Julianne | Officer | — | D | Stock Option (Right to Buy) | 1,800 | 86.75 | 156.2K | 0 | — | ↗ |
| 2024-04-15 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 1,204 | 60.40 | 72.7K | 208,122 | — | ↗ |
| 2024-03-20 | Prasad Raju | Officer | A-Award | A | Stock Option (Right to Buy) | 36,168 | 72.94 | 2.64M | 36,168 | — | ↗ |
| 2024-03-20 | Kulkarni Samarth | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 105,000 | 72.94 | 7.66M | 105,000 | — | ↗ |
| 2024-03-20 | KASINGER JAMES R. | Officer | A-Award | A | Stock Option (Right to Buy) | 33,333 | 72.94 | 2.43M | 33,333 | — | ↗ |
| 2024-03-15 | Prasad Raju | Officer | S-Sale | D | Common Shares | 3,524 | 72.69 | 256.2K | 6,476 | — | ↗ |
| 2024-03-15 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 20,000 | 19.12 | 382.4K | 228,122 | — | ↗ |
| 2024-03-14 | Prasad Raju | Officer | M-Exempt | D | Restricted Stock Units | 10,000 | 0.00 | — | 30,000 | — | ↗ |
| 2024-03-12 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 4,583 | 74.44 | 341.2K | 208,122 | — | ↗ |
| 2024-03-12 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 1,146 | 74.44 | 85.3K | 61,174 | — | ↗ |
| 2024-03-11 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2024-03-11 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 2,250 | 0.00 | — | 62,320 | — | ↗ |
| 2024-03-10 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 19,250 | 0.00 | — | 57,750 | — | ↗ |
| 2024-03-10 | KASINGER JAMES R. | Officer | M-Exempt | D | Restricted Stock Units | 5,500 | 0.00 | — | 16,500 | — | ↗ |
| 2024-02-27 | George Simeon | Director | A-Award | A | Common Shares | 769,196 | 71.50 | 55.00M | 769,196 | — | ↗ |
| 2024-02-20 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 6,370 | 79.67 | 507.5K | 194,257 | — | ↗ |
| 2024-02-20 | KASINGER JAMES R. | Officer | S-Sale | D | Common Shares | 1,913 | 79.67 | 152.4K | 57,371 | — | ↗ |
| 2024-02-18 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 13,250 | 0.00 | — | 26,500 | — | ↗ |
| 2024-02-18 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 3,825 | 0.00 | — | 59,284 | — | ↗ |
| 2024-02-15 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 20,000 | 19.12 | 382.4K | 207,377 | — | ↗ |
| 2024-01-29 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 50,000 | 19.12 | 956.0K | 100,000 | — | ↗ |
| 2024-01-16 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 20,000 | 19.12 | 382.4K | 207,377 | — | ↗ |
| 2023-10-13 | Prasad Raju | Officer | A-Award | A | Stock Option (Right to Buy) | 13,832 | 44.31 | 612.9K | 13,832 | — | ↗ |
| 2023-10-13 | Morrow Phuong Khanh | Officer | A-Award | A | Stock Option (Right to Buy) | 16,667 | 44.31 | 738.5K | 16,667 | — | ↗ |
| 2023-10-13 | Kulkarni Samarth | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 52,500 | 44.31 | 2.33M | 52,500 | — | ↗ |
| 2023-10-13 | KASINGER JAMES R. | Officer | A-Award | A | Stock Option (Right to Buy) | 16,667 | 44.31 | 738.5K | 16,667 | — | ↗ |
| 2023-06-08 | Treco Douglas A | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 62.59 | 813.7K | 13,000 | — | ↗ |
| 2023-06-08 | High Katherine A | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 62.59 | 813.7K | 13,000 | — | ↗ |
| 2023-06-08 | Greene John | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 62.59 | 813.7K | 13,000 | — | ↗ |
| 2023-06-08 | George Simeon | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 62.59 | 813.7K | 13,000 | — | ↗ |
| 2023-06-08 | Fleming Harold Edward | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 62.59 | 813.7K | 13,000 | — | ↗ |
| 2023-06-08 | Fardis Maria | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 62.59 | 813.7K | 13,000 | — | ↗ |
| 2023-06-08 | Behbahani Ali | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 62.59 | 813.7K | 13,000 | — | ↗ |
| 2023-05-30 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 25,000 | 19.12 | 478.0K | 79,582 | — | ↗ |
| 2023-05-24 | Morrow Phuong Khanh | Officer | F-InKind | D | Common Shares | 2,527 | 65.91 | 166.6K | 4,411 | — | ↗ |
| 2023-05-23 | Morrow Phuong Khanh | Officer | M-Exempt | A | Restricted Stock Units | 6,938 | 0.00 | — | 20,812 | — | ↗ |
| 2023-04-25 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 25,000 | 19.12 | 478.0K | 412,377 | — | ↗ |
| 2023-03-29 | Kulkarni Samarth | Director / Officer | S-Sale | D | Common Shares | 19,719 | 44.37 | 875.0K | 392,658 | — | ↗ |
| 2023-03-14 | Prasad Raju | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 45.15 | 4.52M | 100,000 | — | ↗ |
| 2023-03-13 | Kulkarni Samarth | Director / Officer | F-InKind | D | Common Shares | 4,086 | 43.22 | 176.6K | 387,377 | — | ↗ |
| 2023-03-13 | KASINGER JAMES R. | Officer | F-InKind | D | Common Shares | 1,283 | 43.22 | 55.5K | 53,616 | — | ↗ |
| 2023-03-11 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,000 | 0.00 | — | 18,000 | — | ↗ |
| 2023-03-11 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 2,250 | 0.00 | — | 55,866 | — | ↗ |
| 2023-03-10 | Morrow Phuong Khanh | Officer | A-Award | A | Stock Option (Right to Buy) | 44,620 | 43.22 | 1.93M | 44,620 | — | ↗ |
| 2023-03-10 | Kulkarni Samarth | Director / Officer | A-Award | A | Restricted Stock Units | 77,000 | 0.00 | — | 77,000 | — | ↗ |
| 2023-03-10 | KASINGER JAMES R. | Officer | M-Exempt | D | Restricted Stock Units | 2,833 | 0.00 | — | 0 | — | ↗ |
| 2023-02-27 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 25,000 | 19.12 | 478.0K | 400,988 | — | ↗ |
| 2023-02-21 | Smith Brendan | Officer | F-InKind | D | Common Shares | 1,392 | 48.26 | 67.2K | 5,072 | — | ↗ |
| 2023-02-21 | Kulkarni Samarth | Director / Officer | F-InKind | D | Common Shares | 6,373 | 48.26 | 307.6K | 375,988 | — | ↗ |
| 2023-02-21 | KASINGER JAMES R. | Officer | F-InKind | D | Common Shares | 1,950 | 48.26 | 94.1K | 52,066 | — | ↗ |
| 2023-02-18 | Smith Brendan | Officer | M-Exempt | A | Common Shares | 3,825 | 0.00 | — | 6,464 | — | ↗ |
| 2023-02-18 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Restricted Stock Units | 13,250 | 0.00 | — | 39,750 | — | ↗ |
| 2023-02-18 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 3,825 | 0.00 | — | 54,016 | — | ↗ |
| 2023-01-27 | Kulkarni Samarth | Director / Officer | M-Exempt | A | Common Shares | 25,000 | 19.12 | 478.0K | 394,111 | — | ↗ |
| 2022-12-28 | Kulkarni Samarth | Officer | S-Sale | D | Common Shares | 4,634 | 41.45 | 192.1K | 369,111 | — | ↗ |
| 2022-12-06 | Kulkarni Samarth | Officer | M-Exempt | A | Common Shares | 58,233 | 1.81 | 105.4K | 369,111 | — | ↗ |
| 2022-12-05 | Kulkarni Samarth | Officer | F-InKind | D | Common Shares | 19,401 | 52.26 | 1.01M | 310,878 | — | ↗ |
| 2022-12-05 | KASINGER JAMES R. | Officer | F-InKind | D | Common Shares | 3,234 | 52.26 | 169.0K | 50,191 | — | ↗ |
| 2022-12-03 | Kulkarni Samarth | Officer | M-Exempt | A | Common Shares | 40,000 | 0.00 | — | 330,279 | — | ↗ |
| 2022-12-03 | KASINGER JAMES R. | Officer | M-Exempt | A | Common Shares | 6,667 | 0.00 | — | 53,425 | — | ↗ |
| 2022-11-28 | Kulkarni Samarth | Officer | S-Sale | D | Common Shares | 5,572 | 54.85 | 305.6K | 292,589 | — | ↗ |
| 2022-10-26 | Kulkarni Samarth | Officer | M-Exempt | A | Common Shares | 5,418 | 19.12 | 103.6K | 315,279 | — | ↗ |
| 2022-10-17 | Smith Brendan | Officer | F-InKind | D | Common Shares | 1,111 | 55.76 | 61.9K | 2,639 | — | ↗ |
| 2022-10-14 | Smith Brendan | Officer | M-Exempt | A | Common Shares | 3,750 | 0.00 | — | 3,750 | — | ↗ |
| 2022-10-07 | Smith Brendan | Officer | A-Award | A | Stock Option (Right to Buy) | 14,000 | 0.00 | — | 14,000 | — | ↗ |
| 2022-10-07 | Morrow Phuong Khanh | Officer | A-Award | A | Stock Option (Right to Buy) | 9,380 | 0.00 | — | 9,380 | — | ↗ |
| 2022-10-07 | KASINGER JAMES R. | Officer | A-Award | A | Stock Option (Right to Buy) | 14,000 | 0.00 | — | 14,000 | — | ↗ |
| 2022-09-28 | Kulkarni Samarth | Officer | M-Exempt | A | Common Shares | 25,000 | 16.21 | 405.3K | 315,279 | — | ↗ |
| 2022-08-29 | Kulkarni Samarth | Officer | S-Sale | D | Common Shares | 20,764 | 66.98 | 1.39M | 290,442 | — | ↗ |
| 2022-08-16 | Smith Brendan | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-08-16 | Kulkarni Samarth | Officer | A-Award | A | Performance-based Restricted Stock Units | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2022-08-16 | Klein Lawrence Otto | Officer | A-Award | A | Restricted Stock Units | 12,500 | 0.00 | — | 12,500 | — | ↗ |
| 2022-08-16 | KASINGER JAMES R. | Officer | A-Award | A | Restricted Stock Units | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-07-27 | Kulkarni Samarth | Officer | S-Sale | D | Common Shares | 12,759 | 75.73 | 966.3K | 294,187 | — | ↗ |
| 2022-06-29 | Kulkarni Samarth | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 25,000 | 12.57 | 314.3K | 8,333 | — | ↗ |
| 2022-06-09 | Treco Douglas A | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-06-09 | High Katherine A | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-06-09 | Greene John | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-06-09 | George Simeon | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-06-09 | Fleming Harold Edward | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-06-09 | Fardis Maria | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-09 | Bolzon Bradley J PhD | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-06-09 | Behbahani Ali | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2022-05-23 | Morrow Phuong Khanh | Officer | A-Award | A | Restricted Stock Units | 27,750 | 0.00 | — | 27,750 | — | ↗ |
| 2022-03-11 | Kulkarni Samarth | Director / Officer | F-InKind | D | Common Shares | 5,487 | 62.56 | 343.3K | 285,432 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-14.5K
Shares Outstanding
96.45M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Samarth Kulkarni | Chief Executive Officer & Chairman | 1M | — |
| Naimish Patel | Chief Medical Officer | 858.5K | — |
| James R. Kasinger | General Counsel & Secretary | 780.6K | male |
| Raju Yashaswi Prasad | Chief Financial Officer | 779.6K | — |
| Matthew Porteus | Co-Founder & Scientific Advisory Board Member | — | — |
| Chad A. Cowan | Scientific Founder | — | — |
| Shaun Foy | Co-Founder | — | male |
| Craig C. Mello | Co-Founder & Scientific Advisory Board Member | — | — |
| Daniel G. Anderson | Co-Founder & Scientific Advisory Board Member | — | — |
| Emmanuelle Marie Charpentier | Co-Founder & Scientific Advisory Board Member | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2021-01-05 | 2021-01-15 | James Inhofe | OK | Self | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-12-22 | 2020-12-23 | James Inhofe | OK | Self | Sale (Partial) | $50,001 - $100,000 | ↗ |
| 2018-06-19 | 2018-06-20 | James Inhofe | OK | Self | Sale (Partial) | $15,001 - $50,000 | ↗ |
| 2017-10-19 | 2017-11-08 | James Inhofe | OK | Self | Purchase | $15,001 - $50,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CRSP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
